The Scientific Advisory and Development team at SalioGen Therapeutics focuses on advancing the company's EDIT platform through rigorous scientific research and strategic guidance. This multidisciplinary team, comprising directors, advisors, and scientists, collaborates to refine gene therapy processes and ensure the efficacy and safety of SalioGen's non-viral gene therapies, ultimately contributing to the development of potentially curative treatments.
Beverly Davidson
Scientific Advisor
Ellis J. Neufeld
Scientific Advisor
Jesse B. Owens
Scientific Advisor
John Maraganore
Advisor
Mark McClellan
Advisor
Matthew H. Wilson
Scientific Advisor
Nancy L. Craig
SVP, Genetic Engineering & Mob...
Quinner Baltazar
Associate Director
Subhro Guhathakurta
Executive Director, Platform D...
Thomas Quertermous
Scientific Advisor
View all